APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rasagiline Mesylate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rasagiline Mesylate Tablets Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchRasagiline Mesylate Tablets Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Rasagiline Mesylate Tablets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rasagiline Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rasagiline Mesylate Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rasagiline Mesylate Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rasagiline Mesylate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rasagiline Mesylate Tablets include Teva Pharmaceutical, Sun Pharmaceutical, Sandoz, Mylan, Takeda Pharmaceutical, Taj Pharma, Orchid Pharma, Natco Pharma and Lundbeck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rasagiline Mesylate Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rasagiline Mesylate Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Rasagiline Mesylate Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rasagiline Mesylate Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rasagiline Mesylate Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rasagiline Mesylate Tablets sales, projected growth trends, production technology, application and end-user industry.

Rasagiline Mesylate Tablets Segment by Company

Teva Pharmaceutical

Sun Pharmaceutical

Sandoz

Mylan

Takeda Pharmaceutical

Taj Pharma

Orchid Pharma

Natco Pharma

Lundbeck

Intas Pharmaceuticals

Apotex

Alkem Laboratories

Ajanta Pharma

Rasagiline Mesylate Tablets Segment by Type

0.5 mg/Pcs

1 mg/Pcs

Rasagiline Mesylate Tablets Segment by Application

40-65 Years Old

Under 40 Years Old

Above 65 Years Old

Rasagiline Mesylate Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rasagiline Mesylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rasagiline Mesylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rasagiline Mesylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rasagiline Mesylate Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rasagiline Mesylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rasagiline Mesylate Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rasagiline Mesylate Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5 mg/Pcs Major Manufacturers Table 3. 1 mg/Pcs Major Manufacturers Table 4. Global Rasagiline Mesylate Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. 40-65 Years Old Major Manufacturers Table 6. Under 40 Years Old Major Manufacturers Table 7. Above 65 Years Old Major Manufacturers Table 8. Rasagiline Mesylate Tablets Industry Trends Table 9. Rasagiline Mesylate Tablets Industry Drivers Table 10. Rasagiline Mesylate Tablets Industry Opportunities and Challenges Table 11. Rasagiline Mesylate Tablets Industry Restraints Table 12. Global Rasagiline Mesylate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Rasagiline Mesylate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Rasagiline Mesylate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Rasagiline Mesylate Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 18. Global Rasagiline Mesylate Tablets Sales by Region (2021-2026) & (W Pcs) Table 19. Global Rasagiline Mesylate Tablets Sales by Region (2027-2032) & (W Pcs) Table 20. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2021-2026) Table 21. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2027-2032) Table 22. Global Rasagiline Mesylate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Rasagiline Mesylate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Rasagiline Mesylate Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Rasagiline Mesylate Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Rasagiline Mesylate Tablets Sales Price (US$/K Pcs) of Manufacturers (2021-2026) Table 27. Global Rasagiline Mesylate Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Rasagiline Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Rasagiline Mesylate Tablets Manufacturers, Product Type & Application Table 30. Global Rasagiline Mesylate Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Rasagiline Mesylate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Rasagiline Mesylate Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Rasagiline Mesylate Tablets Sales by Type 2021 VS 2025 VS 2032 (W Pcs) Table 39. Global Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 40. Global Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 41. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2026) Table 42. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2027-2032) Table 43. Global Rasagiline Mesylate Tablets Price by Type (2021-2026) & (US$/K Pcs) Table 44. Global Rasagiline Mesylate Tablets Price by Type (2027-2032) & (US$/K Pcs) Table 45. Global Rasagiline Mesylate Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Rasagiline Mesylate Tablets Sales by Application 2021 VS 2025 VS 2032 (W Pcs) Table 51. Global Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 52. Global Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 53. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2026) Table 54. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2027-2032) Table 55. Global Rasagiline Mesylate Tablets Price by Application (2021-2026) & (US$/K Pcs) Table 56. Global Rasagiline Mesylate Tablets Price by Application (2027-2032) & (US$/K Pcs) Table 57. Teva Pharmaceutical Company Information Table 58. Teva Pharmaceutical Business Overview Table 59. Teva Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 61. Teva Pharmaceutical Recent Development Table 62. Sun Pharmaceutical Company Information Table 63. Sun Pharmaceutical Business Overview Table 64. Sun Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 65. Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 66. Sun Pharmaceutical Recent Development Table 67. Sandoz Company Information Table 68. Sandoz Business Overview Table 69. Sandoz Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 70. Sandoz Rasagiline Mesylate Tablets Product Portfolio Table 71. Sandoz Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 75. Mylan Rasagiline Mesylate Tablets Product Portfolio Table 76. Mylan Recent Development Table 77. Takeda Pharmaceutical Company Information Table 78. Takeda Pharmaceutical Business Overview Table 79. Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 80. Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 81. Takeda Pharmaceutical Recent Development Table 82. Taj Pharma Company Information Table 83. Taj Pharma Business Overview Table 84. Taj Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 85. Taj Pharma Rasagiline Mesylate Tablets Product Portfolio Table 86. Taj Pharma Recent Development Table 87. Orchid Pharma Company Information Table 88. Orchid Pharma Business Overview Table 89. Orchid Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 90. Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio Table 91. Orchid Pharma Recent Development Table 92. Natco Pharma Company Information Table 93. Natco Pharma Business Overview Table 94. Natco Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 95. Natco Pharma Rasagiline Mesylate Tablets Product Portfolio Table 96. Natco Pharma Recent Development Table 97. Lundbeck Company Information Table 98. Lundbeck Business Overview Table 99. Lundbeck Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 100. Lundbeck Rasagiline Mesylate Tablets Product Portfolio Table 101. Lundbeck Recent Development Table 102. Intas Pharmaceuticals Company Information Table 103. Intas Pharmaceuticals Business Overview Table 104. Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 105. Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio Table 106. Intas Pharmaceuticals Recent Development Table 107. Apotex Company Information Table 108. Apotex Business Overview Table 109. Apotex Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 110. Apotex Rasagiline Mesylate Tablets Product Portfolio Table 111. Apotex Recent Development Table 112. Alkem Laboratories Company Information Table 113. Alkem Laboratories Business Overview Table 114. Alkem Laboratories Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 115. Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio Table 116. Alkem Laboratories Recent Development Table 117. Ajanta Pharma Company Information Table 118. Ajanta Pharma Business Overview Table 119. Ajanta Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2021-2026) Table 120. Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio Table 121. Ajanta Pharma Recent Development Table 122. North America Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 125. North America Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 126. North America Rasagiline Mesylate Tablets Sales Price by Type (2021-2026) & (US$/K Pcs) Table 127. North America Rasagiline Mesylate Tablets Sales Price by Type (2027-2032) & (US$/K Pcs) Table 128. North America Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 131. North America Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 132. North America Rasagiline Mesylate Tablets Sales Price by Application (2021-2026) & (US$/K Pcs) Table 133. North America Rasagiline Mesylate Tablets Sales Price by Application (2027-2032) & (US$/K Pcs) Table 134. North America Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 138. North America Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 139. North America Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 140. North America Rasagiline Mesylate Tablets Sales Price by Country (2021-2026) & (US$/K Pcs) Table 141. North America Rasagiline Mesylate Tablets Sales Price by Country (2027-2032) & (US$/K Pcs) Table 142. United States Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 143. Canada Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 144. Europe Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 147. Europe Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 148. Europe Rasagiline Mesylate Tablets Sales Price by Type (2021-2026) & (US$/K Pcs) Table 149. Europe Rasagiline Mesylate Tablets Sales Price by Type (2027-2032) & (US$/K Pcs) Table 150. Europe Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 153. Europe Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 154. Europe Rasagiline Mesylate Tablets Sales Price by Application (2021-2026) & (US$/K Pcs) Table 155. Europe Rasagiline Mesylate Tablets Sales Price by Application (2027-2032) & (US$/K Pcs) Table 156. Europe Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 160. Europe Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 161. Europe Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 162. Europe Rasagiline Mesylate Tablets Sales Price by Country (2021-2026) & (US$/K Pcs) Table 163. Europe Rasagiline Mesylate Tablets Sales Price by Country (2027-2032) & (US$/K Pcs) Table 164. Germany Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 165. France Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 166. U.K. Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 167. Italy Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 169. China Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 170. China Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 171. China Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 172. China Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 173. China Rasagiline Mesylate Tablets Sales Price by Type (2021-2026) & (US$/K Pcs) Table 174. China Rasagiline Mesylate Tablets Sales Price by Type (2027-2032) & (US$/K Pcs) Table 175. China Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 176. China Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 177. China Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 178. China Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 179. China Rasagiline Mesylate Tablets Sales Price by Application (2021-2026) & (US$/K Pcs) Table 180. China Rasagiline Mesylate Tablets Sales Price by Application (2027-2032) & (US$/K Pcs) Table 181. Asia Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 184. Asia Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 185. Asia Rasagiline Mesylate Tablets Sales Price by Type (2021-2026) & (US$/K Pcs) Table 186. Asia Rasagiline Mesylate Tablets Sales Price by Type (2027-2032) & (US$/K Pcs) Table 187. Asia Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 190. Asia Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 191. Asia Rasagiline Mesylate Tablets Sales Price by Application (2021-2026) & (US$/K Pcs) Table 192. Asia Rasagiline Mesylate Tablets Sales Price by Application (2027-2032) & (US$/K Pcs) Table 193. Asia Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 197. Asia Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 198. Asia Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 199. Asia Rasagiline Mesylate Tablets Sales Price by Country (2021-2026) & (US$/K Pcs) Table 200. Asia Rasagiline Mesylate Tablets Sales Price by Country (2027-2032) & (US$/K Pcs) Table 201. Japan Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 202. South Korea Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 203. India Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 204. Australia Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 205. China Taiwan Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 210. SAMEA Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 211. SAMEA Rasagiline Mesylate Tablets Sales Price by Type (2021-2026) & (US$/K Pcs) Table 212. SAMEA Rasagiline Mesylate Tablets Sales Price by Type (2027-2032) & (US$/K Pcs) Table 213. SAMEA Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 216. SAMEA Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 217. SAMEA Rasagiline Mesylate Tablets Sales Price by Application (2021-2026) & (US$/K Pcs) Table 218. SAMEA Rasagiline Mesylate Tablets Sales Price by Application (2027-2032) & (US$/K Pcs) Table 219. SAMEA Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 223. SAMEA Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 224. SAMEA Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 225. SAMEA Rasagiline Mesylate Tablets Sales Price by Country (2021-2026) & (US$/K Pcs) Table 226. SAMEA Rasagiline Mesylate Tablets Sales Price by Country (2027-2032) & (US$/K Pcs) Table 227. Brazil Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 228. Argentina Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 229. Chile Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 230. Colombia Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 231. Peru Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 233. Israel Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 234. UAE Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 235. Turkey Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 236. Iran Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 237. Egypt Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Rasagiline Mesylate Tablets Distributors List Table 241. Rasagiline Mesylate Tablets Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Rasagiline Mesylate Tablets Image Figure 2. Global Rasagiline Mesylate Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rasagiline Mesylate Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5 mg/Pcs Image Figure 5. 1 mg/Pcs Image Figure 6. Global Rasagiline Mesylate Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rasagiline Mesylate Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. 40-65 Years Old Image Figure 9. Under 40 Years Old Image Figure 10. Above 65 Years Old Image Figure 11. Global Rasagiline Mesylate Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Rasagiline Mesylate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Rasagiline Mesylate Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Rasagiline Mesylate Tablets Sales (2021-2032) & (W Pcs) Figure 17. Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Figure 18. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Rasagiline Mesylate Tablets Sales YoY (2021-2032) & (W Pcs) Figure 20. Europe Rasagiline Mesylate Tablets Sales YoY (2021-2032) & (W Pcs) Figure 21. China Rasagiline Mesylate Tablets Sales YoY (2021-2032) & (W Pcs) Figure 22. Asia (Excluding China) Rasagiline Mesylate Tablets Sales YoY (2021-2032) & (W Pcs) Figure 23. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales YoY (2021-2032) & (W Pcs) Figure 24. Global Rasagiline Mesylate Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Rasagiline Mesylate Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Rasagiline Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Rasagiline Mesylate Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Rasagiline Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 31. Global Rasagiline Mesylate Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Rasagiline Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Rasagiline Mesylate Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Rasagiline Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 37. Global Rasagiline Mesylate Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Rasagiline Mesylate Tablets Revenue Share by Type (2021-2032) Figure 40. North America Rasagiline Mesylate Tablets Sales Share by Type (2021-2032) Figure 41. North America Rasagiline Mesylate Tablets Revenue Share by Application (2021-2032) Figure 42. North America Rasagiline Mesylate Tablets Sales Share by Application (2021-2032) Figure 43. North America Rasagiline Mesylate Tablets Revenue Share by Country (2021-2032) Figure 44. North America Rasagiline Mesylate Tablets Sales Share by Country (2021-2032) Figure 45. Europe Rasagiline Mesylate Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Rasagiline Mesylate Tablets Sales Share by Type (2021-2032) Figure 47. Europe Rasagiline Mesylate Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Rasagiline Mesylate Tablets Sales Share by Application (2021-2032) Figure 49. Europe Rasagiline Mesylate Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Rasagiline Mesylate Tablets Sales Share by Country (2021-2032) Figure 51. China Rasagiline Mesylate Tablets Revenue Share by Type (2021-2032) Figure 52. China Rasagiline Mesylate Tablets Sales Share by Type (2021-2032) Figure 53. China Rasagiline Mesylate Tablets Revenue Share by Application (2021-2032) Figure 54. China Rasagiline Mesylate Tablets Sales Share by Application (2021-2032) Figure 55. Asia Rasagiline Mesylate Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Rasagiline Mesylate Tablets Sales Share by Type (2021-2032) Figure 57. Asia Rasagiline Mesylate Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Rasagiline Mesylate Tablets Sales Share by Application (2021-2032) Figure 59. Asia Rasagiline Mesylate Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Rasagiline Mesylate Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Rasagiline Mesylate Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Rasagiline Mesylate Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Rasagiline Mesylate Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Rasagiline Mesylate Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Rasagiline Mesylate Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Rasagiline Mesylate Tablets Sales Share by Country (2021-2032) Figure 67. Rasagiline Mesylate Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Rasagiline Mesylate Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/Pcs
  • 1 mg/Pcs
Applications
  • 40-65 Years Old
  • Under 40 Years Old
  • Above 65 Years Old
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Takeda Pharmaceutical
  • Taj Pharma
  • Orchid Pharma
  • Natco Pharma
  • Lundbeck
  • Intas Pharmaceuticals
  • Apotex
  • Alkem Laboratories
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rasagiline Mesylate Tablets Market by Type
  3. 1.2.1 Global Rasagiline Mesylate Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5 mg/Pcs
  5. 1.2.3 1 mg/Pcs
  6. 1.3 Rasagiline Mesylate Tablets Market by Application
  7. 1.3.1 Global Rasagiline Mesylate Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 40-65 Years Old
  9. 1.3.3 Under 40 Years Old
  10. 1.3.4 Above 65 Years Old
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Rasagiline Mesylate Tablets Market Dynamics
  1. 2.1 Rasagiline Mesylate Tablets Industry Trends
  2. 2.2 Rasagiline Mesylate Tablets Industry Drivers
  3. 2.3 Rasagiline Mesylate Tablets Industry Opportunities and Challenges
  4. 2.4 Rasagiline Mesylate Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rasagiline Mesylate Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rasagiline Mesylate Tablets Revenue by Region
  3. 3.2.1 Global Rasagiline Mesylate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rasagiline Mesylate Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Rasagiline Mesylate Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rasagiline Mesylate Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rasagiline Mesylate Tablets Sales by Region
  9. 3.4.1 Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rasagiline Mesylate Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Rasagiline Mesylate Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Rasagiline Mesylate Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rasagiline Mesylate Tablets Revenue by Manufacturers
  2. 4.1.1 Global Rasagiline Mesylate Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rasagiline Mesylate Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rasagiline Mesylate Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rasagiline Mesylate Tablets Sales by Manufacturers
  6. 4.2.1 Global Rasagiline Mesylate Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rasagiline Mesylate Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rasagiline Mesylate Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rasagiline Mesylate Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rasagiline Mesylate Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rasagiline Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rasagiline Mesylate Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Rasagiline Mesylate Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rasagiline Mesylate Tablets Market CR5 and HHI
  16. 4.8.2 2025 Rasagiline Mesylate Tablets Tier 1, Tier 2, and Tier 3
5 Rasagiline Mesylate Tablets Market by Type
  1. 5.1 Global Rasagiline Mesylate Tablets Revenue by Type
  2. 5.1.1 Global Rasagiline Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rasagiline Mesylate Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rasagiline Mesylate Tablets Sales by Type
  6. 5.2.1 Global Rasagiline Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rasagiline Mesylate Tablets Sales by Type (2021-2032) & (W Pcs)
  8. 5.2.3 Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rasagiline Mesylate Tablets Price by Type
6 Rasagiline Mesylate Tablets Market by Application
  1. 6.1 Global Rasagiline Mesylate Tablets Revenue by Application
  2. 6.1.1 Global Rasagiline Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rasagiline Mesylate Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rasagiline Mesylate Tablets Sales by Application
  6. 6.2.1 Global Rasagiline Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rasagiline Mesylate Tablets Sales by Application (2021-2032) & (W Pcs)
  8. 6.2.3 Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rasagiline Mesylate Tablets Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Sandoz
  14. 7.3.1 Sandoz Company Information
  15. 7.3.2 Sandoz Business Overview
  16. 7.3.3 Sandoz Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sandoz Rasagiline Mesylate Tablets Product Portfolio
  18. 7.3.5 Sandoz Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Rasagiline Mesylate Tablets Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Takeda Pharmaceutical
  26. 7.5.1 Takeda Pharmaceutical Company Information
  27. 7.5.2 Takeda Pharmaceutical Business Overview
  28. 7.5.3 Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  30. 7.5.5 Takeda Pharmaceutical Recent Developments
  31. 7.6 Taj Pharma
  32. 7.6.1 Taj Pharma Company Information
  33. 7.6.2 Taj Pharma Business Overview
  34. 7.6.3 Taj Pharma Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Taj Pharma Rasagiline Mesylate Tablets Product Portfolio
  36. 7.6.5 Taj Pharma Recent Developments
  37. 7.7 Orchid Pharma
  38. 7.7.1 Orchid Pharma Company Information
  39. 7.7.2 Orchid Pharma Business Overview
  40. 7.7.3 Orchid Pharma Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio
  42. 7.7.5 Orchid Pharma Recent Developments
  43. 7.8 Natco Pharma
  44. 7.8.1 Natco Pharma Company Information
  45. 7.8.2 Natco Pharma Business Overview
  46. 7.8.3 Natco Pharma Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Natco Pharma Rasagiline Mesylate Tablets Product Portfolio
  48. 7.8.5 Natco Pharma Recent Developments
  49. 7.9 Lundbeck
  50. 7.9.1 Lundbeck Company Information
  51. 7.9.2 Lundbeck Business Overview
  52. 7.9.3 Lundbeck Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lundbeck Rasagiline Mesylate Tablets Product Portfolio
  54. 7.9.5 Lundbeck Recent Developments
  55. 7.10 Intas Pharmaceuticals
  56. 7.10.1 Intas Pharmaceuticals Company Information
  57. 7.10.2 Intas Pharmaceuticals Business Overview
  58. 7.10.3 Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio
  60. 7.10.5 Intas Pharmaceuticals Recent Developments
  61. 7.11 Apotex
  62. 7.11.1 Apotex Company Information
  63. 7.11.2 Apotex Business Overview
  64. 7.11.3 Apotex Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Apotex Rasagiline Mesylate Tablets Product Portfolio
  66. 7.11.5 Apotex Recent Developments
  67. 7.12 Alkem Laboratories
  68. 7.12.1 Alkem Laboratories Company Information
  69. 7.12.2 Alkem Laboratories Business Overview
  70. 7.12.3 Alkem Laboratories Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio
  72. 7.12.5 Alkem Laboratories Recent Developments
  73. 7.13 Ajanta Pharma
  74. 7.13.1 Ajanta Pharma Company Information
  75. 7.13.2 Ajanta Pharma Business Overview
  76. 7.13.3 Ajanta Pharma Rasagiline Mesylate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio
  78. 7.13.5 Ajanta Pharma Recent Developments
8 North America
  1. 8.1 North America Rasagiline Mesylate Tablets Market Size by Type
  2. 8.1.1 North America Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Rasagiline Mesylate Tablets Price by Type (2021-2032)
  5. 8.2 North America Rasagiline Mesylate Tablets Market Size by Application
  6. 8.2.1 North America Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Rasagiline Mesylate Tablets Price by Application (2021-2032)
  9. 8.3 North America Rasagiline Mesylate Tablets Market Size by Country
  10. 8.3.1 North America Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rasagiline Mesylate Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Rasagiline Mesylate Tablets Market Size by Type
  2. 9.1.1 Europe Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Rasagiline Mesylate Tablets Price by Type (2021-2032)
  5. 9.2 Europe Rasagiline Mesylate Tablets Market Size by Application
  6. 9.2.1 Europe Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Rasagiline Mesylate Tablets Price by Application (2021-2032)
  9. 9.3 Europe Rasagiline Mesylate Tablets Market Size by Country
  10. 9.3.1 Europe Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rasagiline Mesylate Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Rasagiline Mesylate Tablets Market Size by Type
  2. 10.1.1 China Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Rasagiline Mesylate Tablets Price by Type (2021-2032)
  5. 10.2 China Rasagiline Mesylate Tablets Market Size by Application
  6. 10.2.1 China Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Rasagiline Mesylate Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rasagiline Mesylate Tablets Market Size by Type
  2. 11.1.1 Asia Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Rasagiline Mesylate Tablets Price by Type (2021-2032)
  5. 11.2 Asia Rasagiline Mesylate Tablets Market Size by Application
  6. 11.2.1 Asia Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Rasagiline Mesylate Tablets Price by Application (2021-2032)
  9. 11.3 Asia Rasagiline Mesylate Tablets Market Size by Country
  10. 11.3.1 Asia Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rasagiline Mesylate Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rasagiline Mesylate Tablets Market Size by Type
  2. 12.1.1 SAMEA Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rasagiline Mesylate Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Rasagiline Mesylate Tablets Market Size by Application
  6. 12.2.1 SAMEA Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rasagiline Mesylate Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Rasagiline Mesylate Tablets Market Size by Country
  10. 12.3.1 SAMEA Rasagiline Mesylate Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rasagiline Mesylate Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rasagiline Mesylate Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rasagiline Mesylate Tablets Value Chain Analysis
  2. 13.1.1 Rasagiline Mesylate Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rasagiline Mesylate Tablets Production Mode & Process
  6. 13.2 Rasagiline Mesylate Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rasagiline Mesylate Tablets Distributors
  9. 13.2.3 Rasagiline Mesylate Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst